Inspire Plans Intranasal Epinastine Trials Following Licensing Deal With Boehringer Ingelheim
This article was originally published in The Pink Sheet Daily
Executive Summary
The intranasal product will join ophthalmic epinastine (Elestat), which Inspire promotes with partner Allergan.